EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…
Persistent Achieves Top Rankings for the Second Year in a Row in Extel’s Asia Executive Team Survey
Recognized under multiple categories, including Best CEO, Company Board of Directors, Overall…
OTM recognised as the Leading Travel Trade Show in India and Asia, for the Second Year in a Row, in a custom study commissioned by Fairfest Media and conducted by NielsenIQ
The customised study, commissioned by Fairfest Media and conducted by NielsenIQ, the…
